Publications by authors named "Matteo De Monte"

Claim this Profile
R
Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer.
Emma Zattarin, Antonio Marra, Antonella Palazzo, Gaia Griguolo, Claudio Vernieri, Matteo De Monte

NPJ Breast Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ICIs Exceptional Long Response in TNBC: Addressing the Issue of Optimal ICIs Duration. Two Cases and Review of the Literature.
Simone Rota, Carolina Sciortino, Silvia Damian, Matteo Duca, Giorgia Villa, Matteo De Monte

Cancer Rep (Hoboken)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib in advanced thyroid, salivary gland, endometrial, and hepatocellular carcinomas: a real-world study on treatment duration and toxicity management.
Elena Colombo, Monika Ducceschi, Stefano Cavalieri, Maggie Polignano, Marta Bini, Matteo De Monte, Giulia Montelatici

Ther Adv Med Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy of the first two doses of anti-SARS-CoV-2 mRNA vaccines in solid cancer patients.
Maria Silvia Cona, Agostino Riva, Davide Dalu, Arianna Gabrieli, Cinzia Fasola, Matteo De Monte

Cancer Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis